Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 54

1.

C-H Functionalization of Heteroarenes Using Unactivated Alkyl Halides through Visible-Light Photoredox Catalysis under Basic Conditions.

Bissonnette NB, Boyd MJ, May GD, Giroux S, Nuhant P.

J Org Chem. 2018 Sep 21;83(18):10933-10940. doi: 10.1021/acs.joc.8b01589. Epub 2018 Aug 23.

PMID:
30092130
2.

'I expected just to walk in, get my tablets and then walk out': on framing new community pharmacy services in the English healthcare system.

Latif A, Waring J, Watmough D, Boyd MJ, Elliott RA.

Sociol Health Illn. 2018 Jul;40(6):1019-1036. doi: 10.1111/1467-9566.12739. Epub 2018 Apr 19.

PMID:
29671885
3.

Generation of Diversity Sets with High sp3 Fraction Using the Photoredox Coupling of Organotrifluoroborates and Organosilicates with Heteroaryl/Aryl Bromides in Continuous Flow.

Raynor KD, May GD, Bandarage UK, Boyd MJ.

J Org Chem. 2018 Feb 2;83(3):1551-1557. doi: 10.1021/acs.joc.7b02680. Epub 2018 Jan 17.

PMID:
29281285
4.

Cost Effectiveness of Support for People Starting a New Medication for a Long-Term Condition Through Community Pharmacies: An Economic Evaluation of the New Medicine Service (NMS) Compared with Normal Practice.

Elliott RA, Tanajewski L, Gkountouras G, Avery AJ, Barber N, Mehta R, Boyd MJ, Latif A, Chuter A, Waring J.

Pharmacoeconomics. 2017 Dec;35(12):1237-1255. doi: 10.1007/s40273-017-0554-9.

5.

Discovery of Novel, Orally Bioavailable β-Amino Acid Azaindole Inhibitors of Influenza PB2.

Farmer LJ, Clark MP, Boyd MJ, Perola E, Jones SM, Tsai A, Jacobs MD, Bandarage UK, Ledeboer MW, Wang T, Deng H, Ledford B, Gu W, Duffy JP, Bethiel RS, Shannon D, Byrn RA, Leeman JR, Rijnbrand R, Bennett HB, O'Brien C, Memmott C, Nti-Addae K, Bennani YL, Charifson PS.

ACS Med Chem Lett. 2017 Jan 20;8(2):256-260. doi: 10.1021/acsmedchemlett.6b00486. eCollection 2017 Feb 9.

6.

Application of the Photoredox Coupling of Trifluoroborates and Aryl Bromides to Analog Generation Using Continuous Flow.

DeLano TJ, Bandarage UK, Palaychuk N, Green J, Boyd MJ.

J Org Chem. 2016 Dec 16;81(24):12525-12531. Epub 2016 Dec 6.

PMID:
27978728
7.

Synthesis of Cycloalkyl Substituted 7-Azaindoles via Photoredox Nickel Dual Catalytic Cross-Coupling in Batch and Continuous Flow.

Palaychuk N, DeLano TJ, Boyd MJ, Green J, Bandarage UK.

Org Lett. 2016 Dec 2;18(23):6180-6183. Epub 2016 Nov 18.

PMID:
27934358
8.

Examination of England's New Medicine Service (NMS) of complex health care interventions in community pharmacy.

Latif A, Waring J, Watmough D, Barber N, Chuter A, Davies J, Salema NE, Boyd MJ, Elliott RA.

Res Social Adm Pharm. 2016 Nov - Dec;12(6):966-989. doi: 10.1016/j.sapharm.2015.12.007. Epub 2015 Dec 29.

PMID:
26806858
9.

Improved scores for observed teamwork in the clinical environment following a multidisciplinary operating room simulation intervention.

Weller JM, Cumin D, Civil ID, Torrie J, Garden A, MacCormick AD, Gurusinghe N, Boyd MJ, Frampton C, Cokorilo M, Tranvik M, Carlsson L, Lee T, Ng WL, Crossan M, Merry AF.

N Z Med J. 2016 Aug 5;129(1439):59-67.

PMID:
27507722
10.

Building research capacity: the value of conferences.

Donyai P, Boyd MJ.

Int J Pharm Pract. 2016 Aug;24(4):227-8. doi: 10.1111/ijpp.12286. No abstract available.

PMID:
27460920
11.

Supporting adherence for people starting a new medication for a long-term condition through community pharmacies: a pragmatic randomised controlled trial of the New Medicine Service.

Elliott RA, Boyd MJ, Salema NE, Davies J, Barber N, Mehta RL, Tanajewski L, Waring J, Latif A, Gkountouras G, Avery AJ, Chuter A, Craig C.

BMJ Qual Saf. 2016 Oct;25(10):747-58. doi: 10.1136/bmjqs-2015-004400. Epub 2015 Dec 8.

12.

Isosteric replacements of the carboxylic acid of drug candidate VX-787: Effect of charge on antiviral potency and kinase activity of azaindole-based influenza PB2 inhibitors.

Boyd MJ, Bandarage UK, Bennett H, Byrn RR, Davies I, Gu W, Jacobs M, Ledeboer MW, Ledford B, Leeman JR, Perola E, Wang T, Bennani Y, Clark MP, Charifson PS.

Bioorg Med Chem Lett. 2015 May 1;25(9):1990-4. doi: 10.1016/j.bmcl.2015.03.013. Epub 2015 Mar 14. Erratum in: Bioorg Med Chem Lett. 2016 Jan 1;26(1):240.

PMID:
25827523
13.

Revision workshops in elementary mathematics enhance student performance in routine laboratory calculations.

Sawbridge JL, Qureshi HK, Boyd MJ, Brown AM.

Adv Physiol Educ. 2014 Sep;38(3):239-45. doi: 10.1152/advan.00036.2014.

14.

Discovery of a novel, first-in-class, orally bioavailable azaindole inhibitor (VX-787) of influenza PB2.

Clark MP, Ledeboer MW, Davies I, Byrn RA, Jones SM, Perola E, Tsai A, Jacobs M, Nti-Addae K, Bandarage UK, Boyd MJ, Bethiel RS, Court JJ, Deng H, Duffy JP, Dorsch WA, Farmer LJ, Gao H, Gu W, Jackson K, Jacobs DH, Kennedy JM, Ledford B, Liang J, Maltais F, Murcko M, Wang T, Wannamaker MW, Bennett HB, Leeman JR, McNeil C, Taylor WP, Memmott C, Jiang M, Rijnbrand R, Bral C, Germann U, Nezami A, Zhang Y, Salituro FG, Bennani YL, Charifson PS.

J Med Chem. 2014 Aug 14;57(15):6668-78. doi: 10.1021/jm5007275. Epub 2014 Jul 24.

PMID:
25019388
15.

The effect of the electronic transmission of prescriptions on dispensing errors and prescription enhancements made in English community pharmacies: a naturalistic stepped wedge study.

Franklin BD, Reynolds M, Sadler S, Hibberd R, Avery AJ, Armstrong SJ, Mehta R, Boyd MJ, Barber N.

BMJ Qual Saf. 2014 Aug;23(8):629-38. doi: 10.1136/bmjqs-2013-002776. Epub 2014 Apr 17.

16.

What proportion of prescription items dispensed in community pharmacies are eligible for the New Medicine Service?

Wells KM, Boyd MJ, Thornley T, Boardman HF.

BMC Health Serv Res. 2014 Mar 7;14:115. doi: 10.1186/1472-6963-14-115.

17.

Assessing the safety features of electronic patient medication record systems used in community pharmacies in England.

Ojeleye O, Avery AJ, Boyd MJ.

Br J Clin Pharmacol. 2014 Aug;78(2):401-9. doi: 10.1111/bcp.12347.

18.

Approaches to learning for the ANZCA Final Examination and validation of the revised Study Process Questionnaire in specialist medical training.

Weller JM, Henning M, Civil N, Lavery L, Boyd MJ, Jolly B.

Anaesth Intensive Care. 2013 Sep;41(5):631-40.

19.

Views and experiences of community pharmacists and superintendent pharmacists regarding the New Medicine Service in England prior to implementation.

Wells KM, Thornley T, Boyd MJ, Boardman HF.

Res Social Adm Pharm. 2014 Jan-Feb;10(1):58-71. doi: 10.1016/j.sapharm.2013.03.003. Epub 2013 Apr 19.

PMID:
23608701
20.

A systematic review of simulation for multidisciplinary team training in operating rooms.

Cumin D, Boyd MJ, Webster CS, Weller JM.

Simul Healthc. 2013 Jun;8(3):171-9. doi: 10.1097/SIH.0b013e31827e2f4c. Review.

PMID:
23343841
21.

The relationship between adolescents' news media use and civic engagement: the indirect effect of interpersonal communication with parents.

Boyd MJ, Zaff JF, Phelps E, Weiner MB, Lerner RM.

J Adolesc. 2011 Dec;34(6):1167-79. doi: 10.1016/j.adolescence.2011.07.004.

PMID:
22118509
22.

Difluoroethylamines as an amide isostere in inhibitors of cathepsin K.

Isabel E, Mellon C, Boyd MJ, Chauret N, Deschênes D, Desmarais S, Falgueyret JP, Gauthier JY, Khougaz K, Lau CK, Léger S, Levorse DA, Li CS, Massé F, Percival MD, Roy B, Scheigetz J, Thérien M, Truong VL, Wesolowski G, Young RN, Zamboni R, Black WC.

Bioorg Med Chem Lett. 2011 Feb 1;21(3):920-3. doi: 10.1016/j.bmcl.2010.12.070. Epub 2010 Dec 19.

PMID:
21232956
23.

Media literacy and positive youth development.

Boyd MJ, Dobrow J.

Adv Child Dev Behav. 2011;41:251-71. Review.

PMID:
23259195
24.

A novel series of potent and selective EP(4) receptor ligands: facile modulation of agonism and antagonism.

Boyd MJ, Berthelette C, Chiasson JF, Clark P, Colucci J, Denis D, Han Y, Lévesque JF, Mathieu MC, Stocco R, Therien A, Rowland S, Wrona M, Xu D.

Bioorg Med Chem Lett. 2011 Jan 1;21(1):484-7. doi: 10.1016/j.bmcl.2010.10.106. Epub 2010 Oct 28.

PMID:
21126875
25.

Zinc chloride-promoted aryl bromide-alkyne cross-coupling reactions at room temperature.

Finke AD, Elleby EC, Boyd MJ, Weissman H, Moore JS.

J Org Chem. 2009 Nov 20;74(22):8897-900. doi: 10.1021/jo902015w.

PMID:
19860393
26.

Investigation of ketone warheads as alternatives to the nitrile for preparation of potent and selective cathepsin K inhibitors.

Boyd MJ, Crane SN, Robichaud J, Scheigetz J, Black WC, Chauret N, Wang Q, Massé F, Oballa RM.

Bioorg Med Chem Lett. 2009 Feb 1;19(3):675-9. doi: 10.1016/j.bmcl.2008.12.053. Epub 2008 Dec 24.

PMID:
19117756
27.

Unusually difficult ring removal from a finger solved using a dental instrument.

Taylor SP, Boyd MJ.

Emerg Med Australas. 2005 Jun;17(3):285-7.

PMID:
15953234
28.

Catalysis of ester aminolysis by cyclodextrins. The reaction of alkylamines with p-nitrophenyl alkanoates

Gadosy TA, Boyd MJ, Tee OS.

J Org Chem. 2000 Oct 20;65(21):6879-89.

PMID:
11031005
29.

A multisite trial comparing two cytomegalovirus (CMV) pp65 antigenemia test kits, biotest CMV brite and Bartels/Argene CMV antigenemia.

St George K, Boyd MJ, Lipson SM, Ferguson D, Cartmell GF, Falk LH, Rinaldo CR, Landry ML.

J Clin Microbiol. 2000 Apr;38(4):1430-3.

30.

An "uninteresting scrawl": some correspondence of Marmaduke Tunstall (1743-1790).

Jessop L, Boyd MJ.

Arch Nat Hist. 1999;26(1):121-42. No abstract available.

PMID:
19378498
31.

Mortality from cardiac arrest.

Gupta S, Foran JP, Bown RL, Boyd MJ, Brown RL.

Lancet. 1995 Oct 7;346(8980):979. No abstract available. Erratum in: Lancet 1995 Oct 21;346(8982):1110.

PMID:
7564775
32.

Coronary atheroma regression trials.

Gupta S, Frankel RJ, Boyd MJ.

Lancet. 1992 May 16;339(8803):1243. No abstract available.

PMID:
1349986
33.

Sudden death due to ventricular tachycardia during amiodarone therapy in familial hypertrophic cardiomyopathy.

Gilligan DM, Missouris CG, Boyd MJ, Oakley CM.

Am J Cardiol. 1991 Oct 1;68(9):971-3. No abstract available.

PMID:
1927963
34.

Capillary haemangiomas: an approach to their management.

Boyd MJ, Collin JR.

Br J Ophthalmol. 1991 May;75(5):298-300.

35.

Detection and partial characterization of human B cell colony stimulating activity in synovial fluids of patients with rheumatoid arthritis.

Fay AC, Trudgett A, McCrea JD, Kirk F, Thompson JM, Mitchell ES, Boyd MJ, Roberts SD, McNeill TA.

Clin Exp Immunol. 1985 May;60(2):316-22.

36.

Pulmonary arterial hypertension and emphysema.

Williams IP, Boyd MJ, Humberstone AM, Wilson AG, Millard FJ.

Br J Dis Chest. 1984 Jul;78(3):211-6.

PMID:
6743518
37.

IV infusion devices--make the right choice.

Boyd MJ.

Health Care (Don Mills). 1983 Apr 14;25(3):25-6. No abstract available.

PMID:
10259500
38.

Intravenous amiodarone in ventricular fibrillation.

Chapman JR, Boyd MJ.

Br Med J (Clin Res Ed). 1981 Mar 21;282(6268):951-2. No abstract available.

39.

Echocardiographic method for the estimation of pulmonary artery pressure in chronic lung disease.

Boyd MJ, Williams IP, Turton CW, Brooks N, Leech G, Millard FJ.

Thorax. 1980 Dec;35(12):914-9.

40.

Changes in red cell deformability and other haemorrheological variables after myocardial infarction.

Dodds AJ, Boyd MJ, Allen J, Bennett ED, Flute PT, Dormandy JA.

Br Heart J. 1980 Nov;44(5):508-11.

41.

Heart size and function in acromegaly.

Mather HM, Boyd MJ, Jenkins JS.

Br Heart J. 1979 Jun;41(6):697-701.

42.

Bradykinin inhibition by serum from animals subjected to thermal injury.

Boyd MJ, Rozmanith JS, Carpel E, Greenberg D.

Proc Soc Exp Biol Med. 1971 Dec;138(3):1091-5. No abstract available.

PMID:
5167180
43.

The metabolism of nickel. I. Spatial and temporal distribution of Ni63 in the mouse.

WASE AW, GOSS DM, BOYD MJ.

Arch Biochem Biophys. 1954 Jul;51(1):1-4. No abstract available.

PMID:
13181453
44.

Effect of total body x-irradiation on some enzymes of rat tissues.

ROTH JS, EICHEL HJ, WASE A, ALPER C, BOYD MJ.

Arch Biochem Biophys. 1953 May;44(1):95-101. No abstract available.

PMID:
13058356
45.

The use of infrared absorption techniques in the study of hypersensitivity diseases.

AGNEW JT, LISAN P, BOYD MJ.

J Opt Soc Am. 1952 Nov;42(11):815-7. No abstract available.

PMID:
13011670
46.

Effects of fluoride on developing bones in tissue culture.

PAFF GH, BOYD MJ.

Proc Soc Exp Biol Med. 1952 Mar;79(3):518-20. No abstract available.

PMID:
14920480
47.

A microbiological procedure for the assay of amino acids with Clostridium perfringens (welchii) BP6K.

BOYD MJ, LOGAN MA, TYTELL AA.

J Biol Chem. 1948 Jul;174(3):1027-35. No abstract available.

PMID:
18871260
48.

The growth requirements of Clostridium perfringens (welchii) BP6K.

BOYD MJ, LOGAN MA, TYTELL AA.

J Biol Chem. 1948 Jul;174(3):1013-25. No abstract available.

PMID:
18871259
49.

Growth of Clostridium welchii (BP6K).

BOYD MJ, LOGAN MA, TYTELL AA.

J Biol Chem. 1947 Mar;167(3):879. No abstract available.

PMID:
20287926
50.

Growth requirements of Clostridium welchii.

BOYD MJ, LOGAN MA, TYTELL AA.

Fed Proc. 1947;6(1 Pt 2):242. No abstract available.

PMID:
20245760

Supplemental Content

Support Center